Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

ANTH 2.87 -0.01 (-0.35%)
price chart
Anthera Pharmaceuticals Announces Personnel Changes
HAYWARD, Calif., March 31, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) , a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced the appointment of ...
Related articles »  
Anthera Pharmaceuticals Inc Announces CFO Change-Form 8-K